ESRRA and breast carcinoma: The MEK/MAPK and PI3K/Akt signalling pathways regulate ERRα transcriptional activity and promote the malignant behaviour of breast cancer cells through increasing ERRα [25], while the overexpression of ERRα also negatively regulates ERK activation [27].